Patents by Inventor John P. DOWLING

John P. DOWLING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11834493
    Abstract: Provided herein are antibodies that are useful for treating SARS-CoV-2 infections in a subject. Also provided herein are compositions comprising one or more antibodies, methods of treatment comprising administering one or more antibodies, and kits comprising one or more antibodies.
    Type: Grant
    Filed: January 4, 2022
    Date of Patent: December 5, 2023
    Assignee: IMMUNOME, INC.
    Inventors: Matthew K. Robinson, Pavel Nikitin, Michael John Morin, Jillian Dimuzio, Ray Howanski, John P. Dowling
  • Publication number: 20220275077
    Abstract: This invention relates to antibodies specific for human interleukin-38 (IL-38), including isolated antibodies, or antigen-binding fragments thereof. The antibodies, or antigen-binding fragments thereof, described here partially or fully block, inhibit, or neutralize a biological activity of IL 38. Methods described here relate to inhibiting tumor growth or metastasis in an individual afflicted by tumor growth and/or metastasis.
    Type: Application
    Filed: July 30, 2020
    Publication date: September 1, 2022
    Inventors: Matthew K. ROBINSON, Karen LUNDGREN, Ben HARMAN, Pavel A. NIKITIN, John P. DOWLING
  • Publication number: 20220235118
    Abstract: Provided herein are antibodies that are useful for treating SARS-CoV-2 infections in a subject. Also provided herein are compositions comprising one or more antibodies, methods of treatment comprising administering one or more antibodies, and kits comprising one or more antibodies.
    Type: Application
    Filed: January 4, 2022
    Publication date: July 28, 2022
    Inventors: Matthew K. ROBINSON, Pavel NIKITIN, Michael John MORIN, Jillian DIMUZIO, Ray HOWANSKI, John P. DOWLING